New Super Bowl commercials in 2026 featuring GLP-1 drugs and tennis icon Serena Williams may help normalize their use, and ...

Hims & Hers announced they are scrapping plans to sell a compounded version of the weight loss drug Wegovy after federal ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes, or another condition. And we expect that number to rise now that ...

Leslie Gammons had used a GLP-1 before, but this time things went wrong. Her online doctor increased the dosage and Gammons ...

The guide to how much GLP-1 medications cost, including Ozempic, Wegovy, and Zepbound.

War breaks out over GLP-1 pills as Novo Nordisk takes legal action against Hims & Hers over compounded weight loss drugs.

As the increasingly popular medications reshape the American diet, the dairy case is standing out above the rest.

The former tennis star underwent a huge lifestyle change.

The approval of oral GLP-1 therapies marks a notable evolution in obesity management, expanding therapeutic choice beyond injectable options. Although this development could improve uptake among ...

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...

Popular medications like Ozempic and Wegovy transform American waistlines, but a KING 5 investigation finds a troubling surge ...

GLP 1 receptor agonists were associated with higher incident chronic cough in adults with type 2 diabetes, with risk ...